top of page
Media Center

Study indicates enGenes Biotech’s Shiga Toxin B subunits useful as drug carriers in cancer therapy
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) has led a new study investigating potential...


enGenes Biotech bringing enhanced product yield opportunities to BIO-Europe Autumn in Germany
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will present its latest technologies at the...

enGenes Biotech makes debut at ICB V continuous biomanufacturing event
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will make its debut at the 5th Integrated...

enGenes development and manufacturing support
enGenes Biotech offers development and manufacturing support services that are highly relevant to companies wishing to develop...

enGenes Biotech to showcase enzyme production offers at Chemspec Europe
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will use the reconvened physical Chemspec Europe...

enGenes participates in the study of large scale production strategies for microbial carbohydrate-binding toxins
Vienna, Austria: – Scientists from recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) have collaborated with researchers...

enGenes Biotech joins TU Munich to study cost-effective protein purification by magnetic nanoparticles
Vienna, Austria: – Scientists from recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) have co-authored a new study that...

Cost-effective recombinant protein production with enGenes-eXpress
enGenes Biotech has developed a leading-edge platform for the customized production of recombinant proteins and plasmid DNA that can...


enGenes presenting -excite Continuous Manufacturing technology to EFIB 2021 Vienna
Vienna, Austria: – Recombinant protein specialist manufacturer enGenes Biotech GmbH (enGenes) will present its innovative decoupled...

enGenes -express achieves high yield SARS CoV-2 nucleocapsid protein expression
enGenes -express achieves high yield SARS CoV-2 nucleocapsid protein expression News-ReleasesEnGenes Biotech GmbH August 26th 2021...
bottom of page